Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias.

Autor: Tabbara N; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Sharp J; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Gaut D; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Pham TTD; Molecular, Cellular, and Integrative Physiology, University of California Los Angeles, Los Angeles, California, USA., Tang K; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Oliai C; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Sim MS; Division of General Internal Medicine and Health Services Research, Department of Medicine Statistics Core, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Schiller G; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Young P; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.; Division of Hematology/Oncology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Sasine JP; Division of Hematology and Cellular Therapy, Department of Medicine, Samuel Oschin Cancer Center, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Jazyk: angličtina
Zdroj: American journal of hematology [Am J Hematol] 2022 Jul; Vol. 97 (7), pp. E249-E255. Date of Electronic Publication: 2022 Apr 11.
DOI: 10.1002/ajh.26551
Databáze: MEDLINE